| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/27/2013 | US20130164349 Pulmonary Delivery for Levodopa |
| 06/27/2013 | US20130164347 Multilayer polymeric drug delivery system |
| 06/27/2013 | US20130164346 Method for preparing biomedical metal alloy material with multi-drug delivery system |
| 06/27/2013 | US20130164345 Co-Processing Method and Formulations for HIV Attachment Inhibitor Prodrug Compound and Excipients |
| 06/27/2013 | US20130164344 Stable powder formulation containing an anticholingeric agent |
| 06/27/2013 | US20130164342 Formulations for osteoporosis |
| 06/27/2013 | US20130164341 Preparation of formulations of angiotensin ii at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 06/27/2013 | US20130164340 Tropoelastins and uses thereof |
| 06/27/2013 | US20130164337 Antimicrobial action pharmaceutical composition for parenteral administration and its production process |
| 06/27/2013 | US20130164336 Antimicrobial and anti-inflammatory action pharmaceutical composition for parenteral administration and its production process |
| 06/27/2013 | US20130164335 Methods and compositions for cellular drug release |
| 06/27/2013 | US20130164285 Water-in-Oil Type Emulsion for Treating a Disease of the Eye |
| 06/27/2013 | US20130164273 Reversibly inactivated acidified plasmin composition |
| 06/27/2013 | US20130164250 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof |
| 06/27/2013 | US20130164226 Foamable aerosol composition |
| 06/27/2013 | US20130164225 Foamable vehicle and pharmaceutical compositions thereof |
| 06/27/2013 | DE102011121804A1 Effect pigment useful e.g. in paints, automobile lacquers, printing inks and plastic, comprises platelet-shaped substrate having specific circular shape factor, which is coated with a high refractive index layer having high refractive index |
| 06/27/2013 | DE102011089947A1 Composition as an oil or water emulsion, useful e.g. for wound healing, comprises water, carboxymethyl cellulose, preservative, silicone oil and/or paraffin oil, silicon dioxide particles, polyol, oil or water emulsifier, and organic acid |
| 06/27/2013 | DE102011089334A1 Detektionssystem zur Erfassung magnetischer Objekte im menschlichen Organismus Detection system for detecting magnetic properties in the human body |
| 06/27/2013 | CA2858257A1 Liquid activation system |
| 06/27/2013 | CA2858255A1 Aqueous dispersions and precursors thereof |
| 06/27/2013 | CA2857604A1 Liposomal chlorite or chlorate compositions |
| 06/27/2013 | CA2856054A1 An inhaler comprising a tiotropium-containing-composition |
| 06/27/2013 | CA2856047A1 An inhalable medicament comprising tiotropium |
| 06/27/2013 | CA2855891A1 Adhesive patch assembly with overlay liner and system and method for making same |
| 06/27/2013 | CA2855890A1 Dialysis precursor composition |
| 06/27/2013 | CA2855889A1 Dialysis precursor composition |
| 06/27/2013 | CA2853689A1 Method of producing lipid nanoparticles for drug delivery |
| 06/26/2013 | EP2606956A1 Atomization device |
| 06/26/2013 | EP2606915A2 Functionalized adhesive medical gel |
| 06/26/2013 | EP2606899A1 High viscosity macromolecluar compositions for treating ocular conditions |
| 06/26/2013 | EP2606898A1 Composition comprising ligustroflavone, rhoifolin and hyperin, and use thereof in the preparation of a medicament |
| 06/26/2013 | EP2606896A1 Sterile emulsion containing hyaluronate and glucocorticoid, and use of such emulsion in the treatment of inflammatory joint disorders |
| 06/26/2013 | EP2606895A1 Transdermal absorption patch of antiviral drug and its preparation method |
| 06/26/2013 | EP2606892A1 An inhaler comprising a tiotropium-containing-composition |
| 06/26/2013 | EP2606891A1 An inhalable medicament comprising tiotropium |
| 06/26/2013 | EP2606880A1 Coating process with aqueous latex coating |
| 06/26/2013 | EP2606879A1 Multiple unit pellet tablet formulation comprising an opioid |
| 06/26/2013 | EP2606878A1 Granulate and controlled release dosage forms comprising a hygroscopic active ingredient |
| 06/26/2013 | EP2606877A1 Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules |
| 06/26/2013 | EP2606865A1 Compositions for transdermal oxybutynin therapy |
| 06/26/2013 | EP2606828A1 Hyaluronic acid and its use for treating venous insufficiency and varicose veins |
| 06/26/2013 | EP2606155A1 Probiotic composition for oral health |
| 06/26/2013 | EP2605816A2 Circumferential aerosol device for delivering drugs to olfactory epithelium and brain |
| 06/26/2013 | EP2605803A1 Method of stabilizing and sterilizing peptides or proteins |
| 06/26/2013 | EP2605799A2 Conjugates, particles, compositions, and related methods |
| 06/26/2013 | EP2605797A2 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods |
| 06/26/2013 | EP2605792A1 Soluble needle arrays for delivery of influenza vaccines |
| 06/26/2013 | EP2605780A1 Concentrate for medical solutions, production thereof and use thereof in dialysis |
| 06/26/2013 | EP2605779A2 Devices and methods for intravaginal delivery of drugs and other substances |
| 06/26/2013 | EP2605761A1 Device that is implantable in the temporal bone for delivering a material, and hearing aid provided with such a device |
| 06/26/2013 | EP2605760A2 Tablet sleeve for improved performance |
| 06/26/2013 | EP2605759A1 Gastric resistant pharmaceutical or nutraceutical formulation comprising one or more salts of alginic acid |
| 06/26/2013 | EP2605758A2 Controlled release formulations of dronedarone |
| 06/26/2013 | EP2605757A2 Nalbuphine-based formulations and uses thereof |
| 06/26/2013 | EP2605756A2 Functional food compositions and methods |
| 06/26/2013 | EP2605755A1 Particulate substances comprising ceramic particles for delivery of biomolecules |
| 06/26/2013 | EP2605754A1 Compositions and methods for improved organ transplant preservation and acceptance |
| 06/26/2013 | EP2605753A2 Topical gel composition |
| 06/26/2013 | EP2605752A1 Ophthalmic formulations of squalamine |
| 06/26/2013 | EP2605751A1 Phospholipid depot |
| 06/26/2013 | CN203017421U Incent navel paste |
| 06/26/2013 | CN203017420U Glycosuria acupoint therapy sugar conversion paste |
| 06/26/2013 | CN203017419U Active particles containing no chemical additives as well as capsules, troches and granules containing active particles |
| 06/26/2013 | CN1913876B Drug-containing grains and solid preparation containing the grains |
| 06/26/2013 | CN103179989A Small liposomes for delivery of immunogen-encoding rna |
| 06/26/2013 | CN103179984A Pegylated liposomes for delivery of immunogen-encoding RNA |
| 06/26/2013 | CN103179972A Use of storage stable viscous phospholipid depot to treat wounds |
| 06/26/2013 | CN103179970A Transdermal absorption preparation |
| 06/26/2013 | CN103179959A Pendant hydrophile bearing biodegradable compositions and related devices |
| 06/26/2013 | CN103179958A Method of preparing a dry powder from a water bacteria extract-concentrate |
| 06/26/2013 | CN103179957A Pharmaceutical compositions containing dgat1 inhibitor |
| 06/26/2013 | CN103179956A Tamper resistant dosage form comprising an anionic polymer |
| 06/26/2013 | CN103179955A Super-saturating delivery vehicles for poorly water-soluble pharmaceutical and cosmetic active ingredients |
| 06/26/2013 | CN103179954A Tamper resistant dosage form comprising an anionic polymer |
| 06/26/2013 | CN103179953A Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9'-dihydro-3'h-spiro[cylohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 06/26/2013 | CN103179952A Nanoparticle-based tumor-targeted drug delivery |
| 06/26/2013 | CN103179951A Phospholipid depot |
| 06/26/2013 | CN103178365A Coaxial connector having detachable locking sleeve |
| 06/26/2013 | CN103172869A Biodegradable unimolecular multi-support-arm polymer as well as preparation method f and application thereof |
| 06/26/2013 | CN103172845A Polyethylenimine-aliphatic polyester graft polymer as well as preparation method and nanometer particle thereof |
| 06/26/2013 | CN103172662A Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
| 06/26/2013 | CN103169985A Choline analogue modified brain-targeting nano-delivery system and preparation method thereof |
| 06/26/2013 | CN103169978A Temperature control slow release injection for bird immune globulin as well as preparation method and application thereof |
| 06/26/2013 | CN103169977A Hyperbranched polymer nano-drug carrier, and preparation method thereof, anti-cancer drug nanoparticles, anti-cancer drug preparation and preparation method thereof |
| 06/26/2013 | CN103169975A Composite high molecular nano particle, and preparation method and application thereof |
| 06/26/2013 | CN103169969A Preparation method and applications of Ni3C nanoparticles with photo-thermal efficiency |
| 06/26/2013 | CN103169968A Hydrophobic dihydroporphin photosensitizer nanometer pharmaceutic preparation based on albumin as well as preparation method and application of nanometer pharmaceutic preparation |
| 06/26/2013 | CN103169967A Composition for improving female rate of chick embryos and preparation of composition |
| 06/26/2013 | CN103169957A Nano thrombin and preparation method thereof |
| 06/26/2013 | CN103169951A Gel microcapsule with cell recruitment function and preparation method thereof |
| 06/26/2013 | CN103169950A BMP-2 (Bone Morphogenetic Protein-2) sustained release microsphere and preparation method thereof |
| 06/26/2013 | CN103169947A Reconstituted surfactants having improved properties |
| 06/26/2013 | CN103169928A Externally applied traditional Chinese medicine composition for treating dysmenorrhea, as well as preparation method and application thereof |
| 06/26/2013 | CN103169922A Traditional Chinese medicine for treating pathologic jaundice of neonate and preparation method thereof |
| 06/26/2013 | CN103169921A Production method of zedoary turmeric oil microcapsule |
| 06/26/2013 | CN103169912A Improvement for preparation method of Chinese material medical preparation for treating primary hepatic carcinoma |
| 06/26/2013 | CN103169911A Chinese medicinal herb gel for treating gastrorrhoea |
| 06/26/2013 | CN103169908A Cough and asthma relieving syrup and preparation method thereof |
| 06/26/2013 | CN103169907A Traditional Chinese medicine tablet preparation for treating lung-heart disease and preparation method thereof |